Publication | Closed Access
A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis
10
Citations
0
References
2001
Year
Interim AnalysisAdvanced Breast CancerBreast OncologyMedicinePhase Iii TrialBreast CancerCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!